Background: Use of total laboratory automation (TLA) system has expanded to microbiology and hemostasis and upgraded to second and third generations. We herein report the first successful upgrades and fusion of different versions of the TLA system, thus improving laboratory turnaround time (TAT).
Methods:
A 21-day schedule was planned from the time of pre-meeting to installation and clinical sample application. We analyzed the monthly TAT in each menu, distribution of the "out of range for acceptable TAT" samples, and "prolonged time out of acceptable TAT," before and after the upgrade and fusion.
Results:
We installed and customized hardware, middleware, and software. The oneway CliniLog 2.0 version track, 50.0-m long, was changed to a 23.2-m long one-way 2.0 version and an 18.7-m long two-way 4.0 version. The monthly TAT in the outpatient samples, before and after upgrading the TLA system, were uniformly satisfactory in the chemistry and viral marker menus. However, in the tumor marker menu, the target TAT (98.0% of samples ≤60 minutes) was not satisfied during the familiarization period. There was no significant difference in the proportion of "out of acceptable TAT" samples, before and after the TLA system upgrades (7.4‰ and 8.5‰). However, the mean "prolonged time out of acceptable TAT" in the chemistry samples was significantly shortened to 17.4 (±24.0) minutes after the fusion, from 34.5 (±43.4) minutes.
Conclusions:
Despite experimental challenges, a fusion of the TLA system shortened the "prolonged time out of acceptable TAT," indicating a distribution change in overall TAT.
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laboratory quality, out of turnaround time sample, total automation system, total laboratory automation, turnaround time hospital laboratories. 9 In the early days of TLA introduction, middleto large-sized hospital laboratories were targeted; however, in recent times, it is also being introduced into small-or medium-sized hospital laboratories and 24-hour satellite laboratories. [10] [11] [12] Hospitals that introduced the TLA system in Korea, in the early stages, are now in the process of replacing the system with its second-or third-generation versions.
There are two concerns for hospital laboratories that are in the process of replacing TLA systems: efficiency and cost. [12] [13] [14] In terms of efficiency, it is to be noted that the tracks, modules, and connected devices that make up the TLA system do not age at the same rate.
Therefore, replacing the entire system at once is a waste of medical resources. In terms of cost, even for large hospitals with strong financial resources, replacing the entire TLA system of the laboratory at the same time can prove to be costly. This is even more difficult in the healthcare environment of the Republic of Korea, where medical expenses are tightly controlled by the government. Therefore, sequential replacement with time differences seems to be inevitable when upgrading a TLA system in the country. The purpose of this study was to share the experience of successfully upgrading the TLA system to help laboratories facing similar challenges regarding simultaneous sequential expiration of multiple laboratory auto-analyzers and a cost burden.
| MATERIALS AND METHODS

| Laboratory setup
The NCC is a complex comprising a cancer hospital, health promo- 
| Upgrading the total laboratory automation system
Multiple analyzers in clinical chemistry and diagnostic immunology, with various laboratory disciplines, were linked to the track. Table 1 shows the layout along with a brief description of the first-and second-generation TLA systems, and each component that was connected to the track.
When upgrading the TLA system, we took several areas for considering logistics and handling issues, facilities and space considerations, mapping workflow, and timed workflow. Working group meetings, including laboratory information system (LIS)/hospital information system (HIS) staff and laboratory staff, were conducted to draw the outline, and simulations were carried out.
A 21-day schedule was planned, from pre-meeting to installation and clinical sample application: -14 days, computer system meeting; -7 days, operation meeting; -3 days, check the location of the work table; upgrade day 1, disconnect the device from the existing TLA system; day 2 ~ 3, access the floor construction; day 4, install the upgraded TLA system; day 5, install 8 analyzer systems and connect them to the LIS; day 6, virtual system test; and day 7, actual patient sample test.
The data management system receives the orders from the LIS 
| Data on turnaround times
During the laboratory test processing at the NCC hospital, four time points were automatically recorded in the LIS: "barcode printing," when the sample barcode was printed by an autolabeler in the phlebotomy room; "scanning," when the sample barcode was scanned at the registration desk of central laboratory after delivery from the phlebotomy room; "result to LIS," when the result was transmitted from the instrument to the LIS after the analysis; and "result to HIS," when the verified result was transmitted from the LIS to the HIS.
In this study, TAT was defined from "scanning" to "result to HIS" to compare the pre-and post-fusion performance of the TLA system.
Retrospective data were extracted from the LIS.
The monthly TAT fulfillment rates of the chemistry menu, tumor marker menu, and viral marker menu were examined before and after TLA fusion. Outpatient samples were tested in the TLA system. TAT data were extracted for 2 months, in which the working days were similar and were considered representative, respectively.
To investigate the pattern of TAT prolongation, we focused on "Out of (acceptable) TAT" samples. More than 99.9% of "Out of TAT" samples were obtained on Monday when there is a concentrated request for analysis for outpatients. After applying exclusion criteria, all "out of acceptable TAT" samples were observed only on
Monday. Accordingly, TAT data were extracted over 10 Mondays (the day for which "out of acceptable TAT" samples present), before and after TLA fusion. Exclusion criteria included a new sample being requested for hemolytic, lipemic, icteric samples, or insufficient quantity. "Prolonged time out of (acceptable) TAT" was defined as "total TAT"-"target TAT. "
| Statistical analysis
Statistical analyses were performed using Microsoft Excel with R program 3.3.2 free software. A Mann-Whitney U test and Student t test were used to verify statistically significant differences between the two groups in data with non-parametric and parametric distributions, respectively. All the probabilities were two-tailed, and P ≤ .05 was considered significant.
| RESULTS
| Upgrade and fusion of the total laboratory automation system
The changes in the hardware, before and after upgrade and fusion, are summarized in Table 1 and Figure 1 . The biggest feature, after upgrade, was the integrated modular system which also has the control function of the individual module, as shown in Figure 1B .
T 
| Monthly TAT fulfillment rates
| Distribution of the samples "out of acceptable TAT"
The target TAT of the outpatient sample for the chemistry analysis is 60 minutes, and the NCC central laboratory aims to satisfy more than 98.0% of this target. We observed the distribution of specimens which were reported after 60 minutes from the time of sample reception (which is considered an acceptable TAT), and defined these as "out of acceptable TAT" samples. Before the upgrade, a total of 6821 tubes were requested from the outpatient clinic, for 10 days. The 6762 tubes were analyzed, except for 59 tubes which met the exclusion criteria. A total of 50 samples were found to be "out of acceptable TAT" (74/1000 = 7.4‰). After the upgrade of the TLA system, a total of 7079 tubes were requested from the outpatient clinic, for 10 days.
The 7036 tubes were analyzed, except for 43 tubes which met the exclusion criteria. A total of 60 samples were "out of acceptable TAT" (8.5‰). After the application of exclusion criteria, it was noted that all "out of acceptable TAT" samples were observed only on Monday.
The sample distribution of the "prolonged time out of TAT (total TAT-target TAT)" is shown in Figure 2 neo) were added and the TLA track was extended. Now, however, due to stepwise equipment expiration, partial replacement and upgrades were inevitable. As in the case of the NCC laboratory, for clinical laboratories across South Korea, TLA systems are no longer new. 9 TLA systems have expanded to microbiology field 2, 5 and hemostasis. 4 The type of automation is also diversified into total automation or sub-total automation. 8, 12, 15 Now, Korean laboratories are faced with the need to upgrade to the second or third generations of the TLA system. We believe that the experiences and results Each menu has a different target TAT and target fulfillment rate. Total requested sample numbers for each month are shown as n. Monthly TAT monitoring results show that both first-and second-generation TLA systems met the target, except in the case of the tumor marker, during the harmonization period.
If the target TAT is not met, it is indicated in bold.
described in this study can help laboratory staffs and directors of clinical laboratories. In our experience, the most important step was customizing (tailoring) the software systems. Even with many simulations, there were errors in the middleware system, in TLA management software, and in connection to LIS. Therefore, to minimize errors and provide the best tailoring, it is essential to obtain accurate and representative laboratory operation data. Multidisciplinary information sharing and co-operation among LIS staff, IT personnel of TLA systems, and medical technicians are needed. There were no problems in the hardware step, including disconnecting the previous TLA and installing the upgraded TLA and laboratory autoanalyzer systems.
The NCC laboratory is currently participating in the CAP survey, a nationwide external proficiency testing in Korea (KEQAS, http://www.
keqas.org/), and Korean Laboratory Accreditation Program (KLAP) by
Laboratory Medicine Foundation (LMF), and makes continuous efforts to improve laboratory quality. As recommended in the Korean KLAP, one of the key laboratory indicators, TAT is under active surveillance to ensure the highest adherence rates. The laboratory director monitors the monthly TAT, and the total TAT is sub-divided by phase. 16 For "out of TAT" samples, the extended phase and reasons behind it are documented every day, and each unit supervisor checks it monthly.
During the familiarization period, after the introduction of the fused TLA system, TAT prolongation was observed due to frequent program errors and equipment errors. The biggest challenge was to stabilize this within a short period.
This fusion was the third TLA system change the NCC laboratory underwent. It is worthy to note that a month after the upgrade, which is the time taken for the hardware to stabilize, the TLA was successfully operated without any errors. In terms of TAT, it can be concluded that the familiarization period for both the equipment and users was less than 3 months, from the time of the upgrade.
The department of laboratory medicine of NCC plans to replace one TBA200fr system with a TBA2000fr system every year, for the next 3 years, moving the fusion contacts to the distal part and eventually completely phasing out the previous version of the track. Through this fusion experience, the 2-year preliminary plan was confirmed.
F I G U R E 2
The Violin Plot shows the distribution shape of the out of turnaround time (TAT) samples. In this figure, that the pattern of "prolonged time out of TAT" is more compressed can be recognized. In the density plot, the vertical line indicates the 95% confidence interval of "prolonged time out of TAT," and the width indicates the frequency. The box indicates the interquartile range, with central horizontal line revealing the 50th percentile. The diamond point in the middle of the box in each group represents the mean value of "prolonged time out of TAT." The mean "prolonged time out of acceptable TAT" in the chemistry samples was significantly shortened to 17.4 (±24.0) min after the fusion, from 34.5 (±43.4) min
In this study, for the first time, authors have succeeded in experimenting with other versions of TLA system fusion. After the familiarization period, the TAT of the laboratory, that is tightly supervised, was found to be satisfactory. In addition, the "prolonged time out of TAT" was shortened. The authors' experience paves the way for sequential upgrades in large laboratories.
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